• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人 HIV 感染者抗逆转录病毒治疗:魁北克艾滋病毒护理委员会向卫生保健专业人员提供的指南。

Antiretroviral therapy for adults infected with HIV: Guidelines for health care professionals from the Quebec HIV care committee.

机构信息

Unité hospitalière de recherche, d'enseignement et de soins sur le sida (UHRESS), Centre hospitalier de l'Université de Montréal;

出版信息

Can J Infect Dis Med Microbiol. 2011 Summer;22(2):52-60. doi: 10.1155/2011/169045.

DOI:10.1155/2011/169045
PMID:22654926
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3142594/
Abstract

The appropriate use of antiretrovirals reduces morbidity and mortality caused by HIV infection. The present article provides health care professionals with a practical guide for the use of antiretrovirals. Therapy should be initiated based predominantly on clinical presentation and CD4 count, and should consist of three active drugs or at least two active drugs when this is not possible, as in cases of some treatment-experienced patients. This is the most effective way to achieve long-term suppression of viral replication. Selection of individual drugs in the regimen should consider the weight of the evidence supporting these choices, as well as their tolerability profiles and ease of use, the patients' comorbidities and treatment history. Treatment interruption is not recommended, either in aviremic patients or in those who have experienced virological failure. Instead, the therapeutic regimen should be adjusted to minimize side effects, promote adherence and suppress viral replication.

摘要

抗逆转录病毒药物的合理使用可降低由 HIV 感染引起的发病率和死亡率。本文为医疗保健专业人员提供了抗逆转录病毒药物使用的实用指南。治疗应主要根据临床表现和 CD4 计数来启动,并应包含三种活性药物,或者在某些治疗经验丰富的患者无法使用两种以上活性药物时使用至少两种活性药物。这是实现长期抑制病毒复制的最有效方法。方案中个体药物的选择应考虑支持这些选择的证据权重,以及它们的耐受性和易用性、患者的合并症和治疗史。不建议中断治疗,无论是在病毒载量抑制的患者还是经历病毒学失败的患者中。相反,应调整治疗方案以最大程度减少副作用、提高患者的依从性并抑制病毒复制。

相似文献

1
Antiretroviral therapy for adults infected with HIV: Guidelines for health care professionals from the Quebec HIV care committee.成人 HIV 感染者抗逆转录病毒治疗:魁北克艾滋病毒护理委员会向卫生保健专业人员提供的指南。
Can J Infect Dis Med Microbiol. 2011 Summer;22(2):52-60. doi: 10.1155/2011/169045.
2
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.人类免疫缺陷病毒基因耐药性检测对治疗效果的影响研究。
Verh K Acad Geneeskd Belg. 2001;63(5):447-73.
3
Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.HIV 感染成人及青少年抗逆转录病毒药物使用指南。
Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433. doi: 10.7326/0003-4819-137-5_part_2-200209031-00001.
4
Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.HIV 感染成人和青少年抗逆转录病毒药物使用指南。HIV 治疗临床实践小组的建议。
MMWR Recomm Rep. 2002 May 17;51(RR-7):1-55.
5
Molecular biological assessment methods and understanding the course of the HIV infection.分子生物学评估方法与对HIV感染病程的理解
APMIS Suppl. 2003(114):1-37.
6
Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.抗逆转录病毒初治和经治的 HIV 感染孕妇在高效抗逆转录病毒治疗下达到病毒载量抑制的时间:对妊娠晚期就诊孕妇的影响。
BJOG. 2013 Nov;120(12):1534-47. doi: 10.1111/1471-0528.12226. Epub 2013 Aug 7.
7
Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.启动高效抗逆转录病毒疗法与艾滋病护理的连续性:监禁和出狱对依从性及艾滋病治疗结果的影响。
Antivir Ther. 2004 Oct;9(5):713-9.
8
Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy.接受高效抗逆转录病毒治疗的HIV感染成人的免疫状态和病毒学抑制情况。
Environ Health Prev Med. 2020 Aug 24;25(1):43. doi: 10.1186/s12199-020-00881-6.
9
Evaluation of the efficacy and safety of changes in antiretroviral regimens for HIV-infected patients.
J Pharm Pharm Sci. 2014;17(3):316-23. doi: 10.18433/j31g7r.
10
Cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, lopinavir-naive, protease inhibitor-resistant, HIV-infected adults in Belgium, Italy, Sweden and the UK.比利时、意大利、瑞典和英国治疗经验丰富、洛匹那韦/利托那韦初治、对蛋白酶抑制剂耐药的 HIV 感染成人中每日两次使用达芦那韦/利托那韦 600/100 mg 的成本效益。
Pharmacoeconomics. 2010;28 Suppl 1:147-67. doi: 10.2165/11587500-000000000-00000.

引用本文的文献

1
Guidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive Individuals.HIV阳性个体认知障碍的评估与管理指南。
Curr HIV/AIDS Rep. 2016 Oct;13(5):235-40. doi: 10.1007/s11904-016-0324-x.
2
Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens.比较单片和多片固定剂量组合HIV治疗方案的研究的Meta分析
Medicine (Baltimore). 2015 Oct;94(42):e1677. doi: 10.1097/MD.0000000000001677.
3
Challenges in initiating antiretroviral therapy in 2010.2010 年启动抗逆转录病毒疗法所面临的挑战。
Can J Infect Dis Med Microbiol. 2010 Aug;21 Suppl C(Suppl C):1C-15C.
4
Persistence versus reversion of 3TC resistance in HIV-1 determine the rate of emergence of NVP resistance.3TC 耐药的持续存在与逆转决定了 NVP 耐药的出现率。
Viruses. 2012 Aug;4(8):1212-34. doi: 10.3390/v4081212. Epub 2012 Aug 7.
5
Management and treatment of hepatitis B virus in patients with HIV infection: A practical guide for health care professionals.HIV 感染者乙型肝炎病毒管理和治疗:卫生保健专业人员实用指南。
Can J Infect Dis Med Microbiol. 2011 Fall;22(3):88-96. doi: 10.1155/2011/686918.

本文引用的文献

1
Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection.在初治的HIV-1感染患者中,联合治疗96周后拉替拉韦的持续抗逆转录病毒作用。
J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):350-6. doi: 10.1097/QAI.0b013e3181b064b0.
2
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.基于拉替拉韦与基于依非韦伦的联合疗法在初治HIV-1感染患者中的安全性和有效性:一项多中心、双盲随机对照试验。
Lancet. 2009 Sep 5;374(9692):796-806. doi: 10.1016/S0140-6736(09)60918-1. Epub 2009 Aug 3.
3
A randomized comparative trial of continued zidovudine/lamivudine or replacement with tenofovir disoproxil fumarate/emtricitabine in efavirenz-treated HIV-1-infected individuals.在接受依非韦伦治疗的HIV-1感染个体中,继续使用齐多夫定/拉米夫定或换用富马酸替诺福韦二吡呋酯/恩曲他滨的随机对照试验。
J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):562-8. doi: 10.1097/QAI.0b013e3181ae2eb9.
4
Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment.阿巴卡韦/拉米夫定或替诺福韦/恩曲他滨联合洛匹那韦/利托那韦用于初始HIV治疗的随机、双盲、安慰剂对照、多中心试验。
AIDS. 2009 Jul 31;23(12):1547-56. doi: 10.1097/QAD.0b013e32832cbcc2.
5
Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment.核苷、非核苷及蛋白酶抑制剂简化治疗方案用于初始HIV治疗的随机试验中的代谢结果
AIDS. 2009 Jun 1;23(9):1109-18. doi: 10.1097/QAD.0b013e32832b4377.
6
A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression.一项简化治疗试验,在病毒学得到抑制的HIV-1感染患者中,从核苷类逆转录酶抑制剂转换为每日一次的固定剂量阿巴卡韦/拉米夫定或替诺福韦/恩曲他滨。
J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):290-7. doi: 10.1097/QAI.0b013e3181aa12d5.
7
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.未患艾滋病的HIV-1感染患者开始抗逆转录病毒治疗的时机:18项HIV队列研究的协作分析
Lancet. 2009 Apr 18;373(9672):1352-63. doi: 10.1016/S0140-6736(09)60612-7. Epub 2009 Apr 8.
8
Risk of myocardial infarction and abacavir therapy: no increased risk across 52 GlaxoSmithKline-sponsored clinical trials in adult subjects.心肌梗死风险与阿巴卡韦治疗:葛兰素史克赞助的52项针对成年受试者的临床试验中未见风险增加。
J Acquir Immune Defic Syndr. 2009 May 1;51(1):20-8. doi: 10.1097/QAI.0b013e31819ff0e6.
9
Gemini: a noninferiority study of saquinavir/ritonavir versus lopinavir/ritonavir as initial HIV-1 therapy in adults.双子座:沙奎那韦/利托那韦与洛匹那韦/利托那韦作为成人初始HIV-1治疗的非劣效性研究。
J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):367-74. doi: 10.1097/QAI.0b013e318198a815.
10
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen.基于非核苷类逆转录酶抑制剂的抑制性治疗方案中断后病毒抑制恢复及耐药性检测
AIDS. 2008 Nov 12;22(17):2279-89. doi: 10.1097/QAD.0b013e328311d16f.